Physician profile
Thomas J Rutherford
NPI 1629068044
$6,279.25
in general payments reported to CMS, 2019-2025
14 companies · $1,699 in 2025
The $1,699 reported for 2025 was more than what 76% of Gynecologic Oncology providers received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $315 · 2021: $184 · 2022: $463 · 2023: $1,893 · 2024: $1,726 · 2025: $1,699.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,800 · Food and Beverage: $1,518.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,800.00 |
| Food and Beverage | $1,518.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $3,584.54 | 2021-2024 | Jemperli, Zejula |
| Abbvie INC. | $852.58 | 2024-2025 | |
| Caris Mpi, INC. | $485.49 | 2025 | Mi Cancer Seek |
| Medtronic, INC. | $325.58 | 2023-2025 | Alligatortm, Synchromedii |
| Genentech USA, INC. | $184.14 | 2019-2022 | |
| Gilead Sciences, INC. | $138.03 | 2025 | Trodelvy |
| Baxter Healthcare | $134.84 | 2022 | |
| Stryker Corporation | $125.42 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $124.83 | 2019 | |
| Eisai INC. | $110.84 | 2023 | |
| Daiichi Sankyo INC. | $105.01 | 2022 | |
| Ethicon US, LLC | $66.66 | 2022-2023 | Stratafix |
| Sanofi Pasteur INC. | $20.83 | 2025 | |
| Coopersurgical, INC. | $20.46 | 2025 | Ally II Ups |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Rutherford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.